Literature DB >> 23104797

Is it necessary to induce labor in cases of intrauterine growth restriction at term?

Tal Shavit1, Eran Ashual, Rivka Regev, Dana Sadeh, Moshe D Fejgin, Tal Biron-Shental.   

Abstract

OBJECTIVES: Infants with intrauterine growth restriction (IUGR) have increased morbidity and mortality. The decision whether to induce labor at term or to expectantly manage these pregnancies is controversial. The aim of this study was to assess the outcomes of these two management strategies in term pregnancies. STUDY
DESIGN: This retrospective cohort study compared neonatal and maternal morbidity and mortality of IUGR fetuses (estimated fetal weight below the 10th percentile) between induced and spontaneous labors.
RESULTS: Records of 669 IUGR newborns were reviewed; 499 were delivered through spontaneous labor and 170 were delivered through induced labor. Epidemiology and early perinatal outcomes between the two groups were similar. The cesarean section rate was significantly higher (P<0.005) in the induced group.
CONCLUSIONS: Expectant management for term IUGR pregnancies seems to be safe, with lower rates of cesarean deliveries. A large, prospective, randomized controlled trial with long-term neonatal follow-up is indicated.

Entities:  

Mesh:

Year:  2012        PMID: 23104797     DOI: 10.1515/jpm-2011-0189

Source DB:  PubMed          Journal:  J Perinat Med        ISSN: 0300-5577            Impact factor:   1.901


  2 in total

1.  Evaluation of eruption of deciduous teeth among infants born after low risk pregnancy compared to infants diagnosed with Intra Uterine Growth Restriction.

Authors:  Aditi Garg; Gyanendra Kumar; Mridula Goswami; Devender Kumar; Devendra Mishra
Journal:  J Oral Biol Craniofac Res       Date:  2021-09-20

2.  Risk of intellectual disability in children born appropriate-for-gestational-age at term or post-term: impact of birth weight for gestational age and gestational age.

Authors:  Ruoqing Chen; Kristina Tedroff; Eduardo Villamor; Donghao Lu; Sven Cnattingius
Journal:  Eur J Epidemiol       Date:  2019-12-02       Impact factor: 8.082

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.